$Citius Pharmaceuticals(CTXR.US)$
Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
Citius Pharmaceuticals, a late-stage biopharmaceutical company, announced a scheduled investor call to discuss the topline results of its Phase 3 Trial of Mino-Lok antibiotic lock solution. The call will take place on Monday, June 3, 2024, at 8:30 AM ET. Citius Chairman and CEO, Leonard Mazur, alongside the management team, will add...

$Selina Hospitality(SLNA.US)$ runnnnnn

$Sunshine Biopharma(SBFM.US)$ lost all my money on this pen stocks are bullshit

$GameStop(GME.US)$ $Pineapple Energy(PEGY.US)$ Gonna fly today

$Pineapple Energy(PEGY.US)$ can we hold it until 0.25?? 🔥🔥🔥

$Citius Pharmaceuticals(CTXR.US)$ Reuters· 5 mins ago
Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution

$Citius Pharmaceuticals(CTXR.US)$
NEWS
Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
Citius Pharmaceuticals announced positive topline results from its Phase 3 clinical trial of Mino-Lok, an antibiotic lock solution for catheter-associated infections. The trial achieved its primary endpoint with a statistically significant improvement in time to catheter failure (p=0.0006). Secondary endpoints showed a higher percentage of p...

$Citius Pharmaceuticals(CTXR.US)$
Bullish Scenario: If the price sustains above $0.70 and breaks through $0.85, it could retest the $1.00 resistance. A move above $1.076 could trigger further buying, potentially driving the price towards $1.20.

$AgriFORCE Growing(AGRI.US)$
@TrendTrader 0.3 possible ?